Clover Biopharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
31 Aug 23 | BuyHK$1,171,242 | Peng Liang | Individual | 1,019,000 | HK$1.15 | |
25 Aug 23 | BuyHK$594,998 | Joshua G. Liang | Individual | 500,000 | HK$1.19 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Employee Share Scheme | 62,518,131 | 4.82% |
Private Companies | 71,870,111 | 5.54% |
VC/PE Firms | 157,593,429 | 12.2% |
Institutions | 227,754,438 | 17.6% |
Individual Insiders | 260,831,370 | 20.1% |
General Public | 516,481,450 | 39.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
209,781,987 | HK$58.7m | 0.07% | no data | |||
157,593,429 | HK$44.1m | 0% | 0.05% | |||
69,999,500 | HK$19.6m | 0% | no data | |||
62,518,131 | HK$17.5m | 0% | no data | |||
58,021,257 | HK$16.2m | 0% | no data | |||
54,696,035 | HK$15.3m | 0% | no data | |||
49,213,878 | HK$13.8m | 0% | no data | |||
35,152,768 | HK$9.8m | 0% | 0.82% | |||
30,660,000 | HK$8.6m | 0% | no data | |||
28,300,750 | HK$7.9m | 0.17% | no data | |||
20,612,402 | HK$5.8m | 1.2% | no data | |||
1,870,611 | HK$523.8k | 0% | no data | |||
753,948 | HK$211.1k | 21.4% | no data | |||
300,750 | HK$84.2k | 19.5% | no data | |||
300,750 | HK$84.2k | 19.5% | no data | |||
300,750 | HK$84.2k | 19.5% | no data | |||
300,750 | HK$84.2k | 19.5% | no data | |||
179,283 | HK$50.2k | 70.1% | no data | |||
5,500 | HK$1.5k | 0% | no data | |||
5,000 | HK$1.4k | 0% | no data |